Morel Rubinger

1.7k citations

38 papers · 723 indexed · h-index 15

Impact in

Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Hemophilia Treatment and Research
Oncology top 10%
- Neutropenia and Cancer Infections
- Viral-associated cancers and disorders

Papers in ⓘ

Hematology 21
- Hematopoietic Stem Cell Transplantation 10
- Acute Myeloid Leukemia Research 6
- Hemophilia Treatment and Research 4
Oncology 16
- Neutropenia and Cancer Infections 8
- Viral-associated cancers and disorders 4

Co-authors: Tsiporah B. Shore (4 shared papers)Eric J. Bow (5 shared papers)Brent Schacter (5 shared papers)David Szwajcer (6 shared papers)Mary Cheang (1 shared paper)Christopher Bredeson (3 shared papers)Matthew D. Seftel (6 shared papers)G. J. Williams (5 shared papers)
Journals: Journal of Clinical Oncology (6 papers)Bone Marrow Transplantation (5 papers)American Journal of Hematology (4 papers)Blood (4 papers)Haemophilia (2 papers)
Partner nations: Canada United States Germany

In The Last Decade

Morel Rubinger

38 papers receiving 706 citations

Peers

Countries citing papers authored by Morel Rubinger

Since Specialization

Citations

This map shows the geographic impact of Morel Rubinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morel Rubinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morel Rubinger more than expected).

Fields of papers citing papers by Morel Rubinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morel Rubinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morel Rubinger. The network helps show where Morel Rubinger may publish in the future.

Co-authors

The 25 scholars most cited alongside Morel Rubinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Morel Rubinger Line = papers co-authored together Morel Rubinger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Cytotoxic therapy-induced D-xylose malabsorption and invasive infection during remission-induction therapy for acute myeloid leukemia in adults. Journal of Clinical Oncology ·Eric J. Bow, R. Loewen, Mary Cheang, Tsiporah B. Shore, Morel Rubinger, Brent Schacter	1997	78
2	Is there ever a role for salvage operations in limited small-cell lung cancer? Journal of Thoracic and Cardiovascular Surgery ·Frances A. Shepherd, Robert J. Ginsberg, G. Alexander Patterson, R. Feld, Paul E. Goss, F.G. Pearson, Thomas J.R. Todd, T. Winton, Morel Rubinger, Else Johansen	1991	71
3	Performance status, but not the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI), predicts mortality at a Canadian transplant center Bone Marrow Transplantation ·Regan Guilfoyle, A Demers, Christopher Bredeson, Erin Richardson, Morel Rubinger, David Szwajcer, Matthew D. Seftel	2008	64
4	Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity Antimicrobial Agents and Chemotherapy ·A Kureishi, Peter J. Jewesson, Morel Rubinger, Cynthia Cole, Donna Reece, G. L. Phillips, John A. Smith, Anthony W. Chow	1991	56
5	Randomized Phase III Study of Fludarabine Phosphate Versus Cyclophosphamide, Vincristine, and Prednisone in Patients With Recurrent Low-Grade Non-Hodgkin’s Lymphoma Previously Treated With an Alkylating Agent or Alkylator-Containing Regimen Journal of Clinical Oncology ·Richard Klasa, Ralph M. Meyer, Chaim Shustik, Carol Sawka, Anne Marie Smith, R. Guévin, Andrew W. Maksymiuk, Morel Rubinger, Martin Samosh, Suzanne Laplante, Jean-François Grenier	2002	47
6	Autologous Is Superior to Allogeneic Hematopoietic Cell Transplantation for Acute Promyelocytic Leukemia in Second Complete Remission Biology of Blood and Marrow Transplantation ·Jennifer L. Holter Chakrabarty, Morel Rubinger, Jennifer Le‐Rademacher, Hailin Wang, Andrew Grigg, George B. Selby, Jeff Szer, Jacob M. Rowe, Daniel J. Weisdorf, Martin S. Tallman	2014	43
7	Therapy of untreated acute myeloid leukemia in the elderly: remission-induction using a non-cytarabine-containing regimen of mitoxantrone plus etoposide. Journal of Clinical Oncology ·Eric J. Bow, Jenny Sutherland, Marilyn G. Kilpatrick, G. J. Williams, Jennifer Clinch, Tsiporah B. Shore, Morel Rubinger, Brent Schacter	1996	39
8	A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucrose Haemophilia ·Morel Rubinger, David Lillicrap, Georges‐Étienne Rivard, Jerome Teitel, Manuel Carção, Caroline Hensman, Irwin Walker	2008	32
9	Expression of P53 Predicts Treatment Failure in Aggressive Non-Hodgkin's Lymphomas Leukemia & lymphoma ·Srisala Navaratnam, G. J. Williams, Morel Rubinger, Norman M. Pettigrew, Michael Mowat, Asher Begleiter, James B. Johnston	1998	25
10	Rhabdomyolysis Induced by Epsilon-Aminocaproic Acid Annals of Pharmacotherapy ·B. Seymour, Morel Rubinger	1997	25
11	Bortezomib Added to R-CVP Is Safe and Effective for Previously Untreated Advanced-Stage Follicular Lymphoma: A Phase II Study by the National Cancer Institute of Canada Clinical Trials Group Journal of Clinical Oncology ·Laurie H. Sehn, David MacDonald, S. Rubin, Guy Cantin, Morel Rubinger, Bernard Lemieux, Sanraj Basi, Kevin Imrie, Randy D. Gascoyne, Jonathan Sussman, Bingshu E. Chen, Marina Djurfeldt, Lois E. Shepherd, Stephen Couban, Michael Crump	2011	24
12	Does gastroenterology consultation change management of patients receiving hematopoietic stem cell transplantation? Bone Marrow Transplantation ·G Fallows, Morel Rubinger, CN Bernstein	2001	21
13	Three-dimensional Nuclear Telomere Organization in Multiple Myeloma Translational Oncology ·Ludger Klewes, Rhea U. Vallente, Eric Dupas, Carolin Brand, Dietrich Grün, Amanda Guffei, Chirawadee Sathitruangsak, Julius Adebayo Awe, Alexandra Kuzyk, Daniel Lichtensztejn, Pille Tammur, Tiiu Ilus, Anu Tamm, Mari Punab, Morel Rubinger, Adebayo Olujohungbe, Sabine Mai	2013	19
14	Continuous infusion of porcine factor VIII in the management of patients with factor VIII inhibitors American Journal of Hematology ·Morel Rubinger, Donald S. Houston, Nora Schwetz, Donna M M Woloschuk, Sara J. Israels, James Johnston	1997	15
15	An epidemiological review of red cell transfusions in cancer chemotherapy. PubMed ·Jamey Skillings, I Rogers-Melamed, J.-M. Nabholtz, C. Sawka, Femida Gwadry‐Sridhar, J.-P. Moquin, Morel Rubinger, Pradip Kumar Ganguly, Margot J. Burnell, Chaim Shustik, D. Dryer, Mark P. McLaughlin, Daniel White	1999	15
16	Early Stage W.H.O. Grade I and II Follicular Lymphoma Treated with Radiation Therapy Alone PLoS ONE ·Naseer Ahmed, Timothy Owen, Morel Rubinger, G. J. Williams, Zoann Nugent, Shahida Ahmed, Andrew Cooke	2013	14
17	High rate of discordance between clinical and autopsy diagnoses in blood and marrow transplantation Bone Marrow Transplantation ·M.D. Seftel, M. Ho, Deepak Pruthi, S Orbanski, Morel Rubinger, Brent Schacter, David Szwajcer, Christopher Bredeson, A Demers	2007	13
18	Does location matter? Rural vs urban outcomes after blood and marrow transplantation in a population-based Canadian cohort Bone Marrow Transplantation ·Kristjan Paulson, Pascal Lambert, Christopher Bredeson, A Demers, Janet Nowatzki, Erin Richardson, Morel Rubinger, David Szwajcer, M.D. Seftel	2009	12
19	Total Body Irradiation Compared With BEAM: Long-Term Outcomes of Peripheral Blood Autologous Stem Cell Transplantation for Non-Hodgkin's Lymphoma International Journal of Radiation OncologyBiologyPhysics ·Hongwei Liu, Matthew D. Seftel, Morel Rubinger, David Szwajcer, Alain Demers, Zoann Nugent, G. Schroeder, James Butler, Andrew Cooke	2010	12
20	Metastatic Extraskeletal Myxoid Chondrosarcoma CHEST Journal ·Morel Rubinger, Ian H. Plenderleith, Morley Lertzman, Ann J. Worth	1995	11

About Morel Rubinger

Morel Rubinger is a scholar working on Hematology, Oncology, Pathology and Forensic Medicine, Molecular Biology and Neurology, having authored 38 papers that have together received 723 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (10 papers), Lymphoma Diagnosis and Treatment (9 papers), Neutropenia and Cancer Infections (8 papers), Acute Myeloid Leukemia Research (6 papers), CNS Lymphoma Diagnosis and Treatment (6 papers), Acute Lymphoblastic Leukemia research (5 papers), Hemophilia Treatment and Research (4 papers) and Viral-associated cancers and disorders (4 papers). The work is most often cited by research in Hematology (307 citations), Oncology (306 citations), Genetics (100 citations), Transplantation (19 citations) and Pathology and Forensic Medicine (124 citations). Morel Rubinger has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Tsiporah B. Shore, Eric J. Bow, Brent Schacter, David Szwajcer, Mary Cheang, Christopher Bredeson, Matthew D. Seftel, G. J. Williams, A Demers and Regan Guilfoyle. Their work appears in journals such as Journal of Clinical Oncology, Bone Marrow Transplantation, American Journal of Hematology, Blood and Haemophilia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact